The federal government is siding with a whistleblower who is suing Pfizer and a subsidiary, accusing them of illegally marketing the epilepsy drug Neurontin and offering lavish kickbacks to doctors. The case concerns "off-label" uses of Neurontin -- prescribing the drug for uses that the FDA has not officially approved.
May 29, 2003 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
Celebrating achievement, excellence, and innovation in the legal profession in the UK.
Join the industry's top owners, investors, developers, brokers and financiers for the real estate healthcare event of the year!
This event shines a spotlight on how individuals and firms are changing the investment advisory industry where it matters most.
Role TitleAssociate General Counsel, Global EmploymentGrade F13Reporting ToSenior Legal Counsel, Global EmploymentProgram/Tool/ Department/U...
Ryan & Conlon, LLP, is a boutique firm specializing in insurance defense. We are a small eclectic practice with a busy and fast paced en...
INTELLECTUAL PROPERTY PROSECUTION PARALEGAL - NEW JERSEY OR NEW YORK OFFICESProminent mid-Atlantic law firm with multiple regional office lo...
